Nealbarbital
From Wikipedia, the free encyclopedia
|
Nealbarbital
|
|
| Systematic (IUPAC) name | |
| 5-(2-methylbutan-2-yl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H18N2O3 |
| Mol. mass | 238.28 g/mol |
| Synonyms | Nealbarbital, Censedal |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Nealbarbital (Censedal) is a barbiturate derivative. It has sedative and hypnotic effects, and was used for the treatment of insomnia.
[edit] References
|
|||||

